Alpine Woods Capital Investors, LLC Gilead Sciences, Inc. Transaction History

Alpine Woods Capital Investors, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$63.47 - $69.35 $25,388 - $27,739	-400 Reduced 7.14%	5,200 $358,000
Q1 2021 May 11, 2021	SELL	$60.0 - $68.46 $12,000 - $13,691	-200 Reduced 3.45%	5,600 $362,000
Q4 2020 Feb 01, 2021	SELL	$56.65 - $64.55 $5.7 Million - $6.49 Million	-100,571 Reduced 94.55%	5,800 $338,000
Q3 2020 Nov 02, 2020	BUY	$62.1 - $78.08 $3.55 Million - $4.46 Million	57,184 Added 116.26%	106,371 $6.72 Million
Q2 2020 Aug 10, 2020	BUY	$72.34 - $84.0 $498,205 - $578,508	6,887 Added 16.28%	49,187 $3.78 Million
Q1 2020 May 04, 2020	BUY	$62.63 - $80.22 $1.66 Million - $2.12 Million	26,444 Added 166.78%	42,300 $3.16 Million
Q4 2019 Feb 07, 2020	BUY	$61.62 - $67.78 $770,250 - $847,250	12,500 Added 372.47%	15,856 $1.03 Million
Q3 2019 Nov 01, 2019	BUY	$62.51 - $69.0 $22,253 - $24,564	356 Added 11.87%	3,356 $213,000
Q2 2019 Aug 05, 2019	SELL	$61.87 - $69.38 $30,935 - $34,690	-500 Reduced 14.29%	3,000 $203,000
Q1 2019 May 06, 2019	SELL	$62.53 - $70.05 $6,253 - $7,005	-100 Reduced 2.78%	3,500 $228,000
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $72,648 - $94,800	-1,200 Reduced 25.0%	3,600 $225,000
Q3 2018 Nov 08, 2018	BUY	$71.28 - $78.92 $35,640 - $39,460	500 Added 11.63%	4,800 $371,000
Q1 2018 May 09, 2018	SELL	$72.84 - $88.8 $94,692 - $115,440	-1,300 Reduced 23.21%	4,300 $324,000
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $711,500 - $835,200	-10,000 Reduced 64.1%	5,600 $401,000
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $1.12 Million - $1.33 Million	15,600	15,600 $1.26 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Alpine Woods Capital Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Woods Capital Investors, LLC with notifications on news.